Clinical characteristics of schizotypal-related obsessive-compulsive disorder

Psychiatry Research

Volumn 159, Issue 1-2, 2008, Pages 254-258

  Poyurovsky, Michael ^a,b   Faragian, Sarit ^a   Pashinian, Artashez ^a   Heidrach, Lilah ^a   Fuchs, Camil ^c   Weizman, Ronit ^c,d   Koran, Lorrin ^e  

^a Technion Medical School   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d TEL AVIV COMMUNITY MENTAL HEALTH CENTER   (Israel)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Obsessive compulsive disorder; Schizophrenia spectrum disorders; Schizotypal personality disorder

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; HALOPERIDOL; OLANZAPINE; PAROXETINE; RISPERIDONE; SERTRALINE;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; PHENOTYPE; PRIORITY JOURNAL; SCHIZOTYPAL PERSONALITY DISORDER; SCORING SYSTEM;

ADULT; AGE OF ONSET; ANTIPSYCHOTIC AGENTS; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ISRAEL; LOGISTIC MODELS; MALE; MENTAL DISORDERS; OBSESSIVE-COMPULSIVE DISORDER; PHENOTYPE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SCHIZOTYPAL PERSONALITY DISORDER; SEVERITY OF ILLNESS INDEX;

EID: 42749086200     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2007.02.019     Document Type: Article

References (20)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (2000), APA, Washington DC 34 Text Revision
2. Andreasen N.C. Scale for the Assessment of Negative Symptoms (SANS) (1983), University of Iowa, Iowa City
3. Andreasen N.C. Scale for the Assessment of Positive Symptoms (SAPS) (1984), University of Iowa, Iowa City
4. Andreasen N.C., Endicott J., Spitzer R.L., and Winokur G. The family history method using diagnostic criteria. Reliability and validity. Archives of General Psychiatry 34 (1977) 1229-1235
5. Bacon S.F., Collins M.J., and Plake E.V. Does the Global Assessment of Functioning (GAF) assess functioning?. Journal of Mental Health Counseling 24 (2002) 202-212
6. Baer L., Jenike M.A., Black D.W., Treece C., Rosenfeld R., and Greist J. Effect of axis II diagnoses on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder. Archives of General Psychiatry 49 (1992) 862-866
7. Dickey C.C., McCarley R.W., Niznikiewicz M.A., Voglmaier M.M., Seidman L.J., Kim S., and Shenton M.E. Clinical, cognitive and social characteristics of a sample of neuroleptic-naive persons with schizotypal personality disorder. Schizophrenia Research 78 (2005) 297-308
8. Eisen J.L., and Rasmussen S.A. Obsessive compulsive disorder with psychotic features. Journal of Clinical Psychiatry 54 (1993) 373-379
9. First M.B., Spitzer R.L., and Gibbon M. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P, version 2.0) (1995), Biometrics Research, New York State Psychiatric Institute, New York, NY
10. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., Heninger G.R., and Charney D.S. The Yale-Brown Obsessive-Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry 46 (1989) 1006-1011
11. Insel T.R., and Akiskal H.C. Obsessive-compulsive disorder with psychotic features: a phenomenologic analysis. American Journal of Psychiatry 143 (1986) 1527-1533
12. Jenike M.A., Baer L., Minichiello W.E., Schwartz C.E., and Carey Jr. R.J. Concomitant obsessive-compulsive disorder and schizotypal personality disorder. American Journal of Psychiatry 143 (1986) 530-532
13. McDougle C.J., Goodman W.K., Price L.H., Delgado P.L., Krystal J.H., Charney D.S., and Heninger G.R. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. American Journal of Psychiatry 147 (1990) 652-654
14. McDougle C.J., Epperson C.N., Pelton G.H., Wasylink S., and Price L.H. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Archives of General Psychiatry 57 (2000) 794-801
15. Miguel E.C., Leckman J.F., Rauch S., do Rosario-Campos M.C., Hounie A.G., Mercadante T., Chacon P., and Pauls D.L. Obsessive-compulsive disorder phenotypes: implications for genetic studies. Molecular Psychiatry 10 (2005) 258-275
16. Poyurovsky M., and Koran L.M. Obsessive-compulsive disorder (OCD) with schizotypy vs. schizophrenia with OCD: diagnostic dilemmas and therapeutic implications. Journal of Psychiatric Research 39 (2005) 399-408
17. Poyurovsky M., Weizman A., and Weizman R. Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment. CNS Drugs 18 (2004) 989-1010
18. Siever L.J., and Davis K.L. The pathophysiology of schizophrenia disorders: perspectives from the spectrum. American Journal of Psychiatry 161 (2004) 398-413
19. Sobin C., Blundell M.L., Weiller F., Gavigan C., Haiman C., and Karayiorgou M. Evidence of a schizotypy subtype in OCD. Journal of Psychiatric Research 34 (2000) 15-24
20. Spitznagel M.B., and Suhr J.A. Executive function deficits associated with symptoms of schizotypy and obsessive-compulsive disorder. Psychiatry Research 110 (2002) 151-163